The Journal of Infectious Diseases · 1996 · 38 citations · 9 references
Veterinary MedicineInfectious DiseasesMicrobiologyMolecular DiagnosticsMolecular VirologyVirologyAntigen Detection AssaysInfectious Disease Molecular TestingViral DiagnosticsViral HepatitisHepatitis B E AntigenHepatitis SerologyHepatitis Virus DiagnosisHepatitis Virus TestingInjecting Drug UseNeedle ExchangeViral Antigen DetectionViral Hepatitis Assessment
Hepatitis virus infections are common among injecting drug users. Syringes containing hepatitis B virus (HBV) DNA and hepatitis C virus (HCV) RNA were identified by polymerase chain reaction (PCR); syringes containing antibodies to HBV core antigen and HCV were identified by EIA. Syringe use was simulated to determine the sensitivity of these assays. The mean limits for PCR were 0.082 microliter of blood for HBV and 0.185 microliter for HCV; the mean limits for EIA were 0.185 microliter for HBV and 0.023 microliter for HCV. HBV PCR testing of 681 syringes returned to the needle exchange program in New Haven, Connecticut, revealed a decline from 7.8% HBV-positive at the program's outset to 2.6%. HCV antibodies were found in 12.1% of 207 syringes tested. Syringe testing can help estimate the prevalence and incidence of hepatitis virus infections when standard seroepidemiologic analyses cannot be applied.
9
Compilation of small ribosomal subunit RNA sequences
Peter De Rijk, Jean‐Marc Neefs, Yves Van de Peer et al. · Nucleic Acids Research · 1992 · 975 citations · Full text
The Changing Epidemiology of Hepatitis B in the United States
Miriam J. Alter · JAMA · 1990 · 437 citations